• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在体内对源自长期潜伏肿瘤的多瘤病毒转化细胞上FcγRII表达的获取。

In vivo acquisition of Fc gamma RII expression on polyoma virus-transformed cells derived from tumors of long latency.

作者信息

Ran M, Katz B, Kimchi N, Halachmi E, Teillaud J L, Even J, Berko-Flint Y, Atlas E, Fridman W H, Witz I P

机构信息

Department of Microbiology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Israel.

出版信息

Cancer Res. 1991 Jan 15;51(2):612-8.

PMID:1845956
Abstract

BALB/c 3T3 cells transformed in vitro with polyoma virus were cloned and passaged once in syngeneic mice. Resulting tumors from each clone were explanted and recultured. Expression of receptor for Fc of IgG (Fc gamma RII) in the original in vitro maintained clones and in cells derived from tumors elicited by the respective cells was measured at the protein level as well as at the mRNA level. Clones were assayed in pairs. The ancestor in vitro maintained clones [designated cultured cells (C)] were compared with cells derived from the same clones after a single passage in vivo followed by explantation and reculturing [designated cultured-tumor-cultured cells (CTC)]. C cells of any of the tested clones did not express Fc gamma RII. On the other hand, certain CTC cells were positive. The Fc gamma RII-positive cells were derived from tumors appearing after a long precancer latency period (greater than 140 days). CTC cells derived from tumors that appeared after shorter latency periods (less than 80 days) were Fc gamma RII negative. These results were obtained both by using radioimmunoassay and monoclonal antibodies against mouse Fc gamma RII as well as by Northern blot analysis using the Fc gamma RII complementary DNA probe. The involvement of macrophages as the Fc gamma RII-expressing cells in CTC cells was excluded. Fc gamma RII expression was down-regulated in CTC cells as a function of time following their explantation into culture. Fc gamma RII expression could be up-regulated in these cells and induced on C cells by maintaining the cultured cells in the presence of normal mouse serum or recombinant interferon. We also tested the expression of Fc gamma RII on CTC cells following their inoculation into syngeneic mice for a second time (CTCx2 cells). The results showed a positive correlation between Fc gamma RII expression in the inoculated ancestor CTC cells and on the CTCx2 cell progeny.

摘要

用多瘤病毒体外转化的BALB/c 3T3细胞被克隆,并在同基因小鼠中传代一次。每个克隆产生的肿瘤被取出并重新培养。在蛋白质水平和mRNA水平上测量原始体外培养克隆以及由相应细胞引发的肿瘤衍生细胞中IgG的Fc受体(FcγRII)的表达。成对检测克隆。将体外培养的原始克隆[称为培养细胞(C)]与在体内单次传代后取出并重新培养的同一克隆衍生的细胞[称为培养-肿瘤-培养细胞(CTC)]进行比较。任何测试克隆的C细胞均不表达FcγRII。另一方面,某些CTC细胞呈阳性。FcγRII阳性细胞来源于癌前潜伏期较长(超过140天)后出现的肿瘤。潜伏期较短(少于80天)后出现的肿瘤衍生的CTC细胞FcγRII呈阴性。这些结果通过使用放射免疫测定和抗小鼠FcγRII单克隆抗体以及使用FcγRII互补DNA探针的Northern印迹分析获得。排除了巨噬细胞作为CTC细胞中表达FcγRII的细胞的参与。FcγRII表达在CTC细胞重新接种到培养基后随时间下调。通过在正常小鼠血清或重组干扰素存在下培养细胞,可使这些细胞中FcγRII表达上调并在C细胞上诱导表达。我们还测试了CTC细胞再次接种到同基因小鼠(CTCx2细胞)后FcγRII的表达。结果显示接种的原始CTC细胞和CTCx2细胞后代中FcγRII表达之间存在正相关。

相似文献

1
In vivo acquisition of Fc gamma RII expression on polyoma virus-transformed cells derived from tumors of long latency.在体内对源自长期潜伏肿瘤的多瘤病毒转化细胞上FcγRII表达的获取。
Cancer Res. 1991 Jan 15;51(2):612-8.
2
Phenotypic properties of 3T3 cells transformed in vitro with polyoma virus and passaged once in syngeneic animals.用多瘤病毒体外转化并在同基因动物中传代一次的3T3细胞的表型特性。
Immunobiology. 1992 Aug;185(2-4):281-91. doi: 10.1016/S0171-2985(11)80646-7.
3
Maturation-related changes in the expression of Fc gamma RII and Fc gamma RIII on mouse mast cells derived in vitro and in vivo.体外和体内衍生的小鼠肥大细胞上FcγRII和FcγRIII表达的成熟相关变化。
J Immunol. 1990 Nov 15;145(10):3412-7.
4
Differential regulation of murine B cell Fc gamma RII expression by CD4+ T helper subsets.CD4⁺辅助性T细胞亚群对小鼠B细胞FcγRII表达的差异调节。
J Immunol. 1989 Oct 1;143(7):2133-41.
5
Differential tumorigenicity of 3T3 cells transformed in vitro with polyoma virus and in vivo selection for high tumorigenicity.经多瘤病毒体外转化并经体内高致瘤性选择的3T3细胞的差异致瘤性
Cancer Res. 1989 May 1;49(9):2383-9.
6
Expression of murine Fc receptors for IgG.小鼠IgG的Fc受体表达
J Immunol. 1990 Jun 15;144(12):4735-41.
7
Ontogeny and distribution of the murine B cell Fc gamma RII.小鼠B细胞FcγRII的个体发生与分布
J Immunol. 1992 Sep 1;149(5):1516-23.
8
Molecular heterogeneity of murine mast cell Fc gamma receptors.小鼠肥大细胞Fcγ受体的分子异质性
J Immunol. 1990 Apr 15;144(8):3071-7.
9
Characterization of Fc gamma receptors on a human erythroleukemia cell line (HEL).人红白血病细胞系(HEL)上Fcγ受体的特性分析。
Exp Hematol. 1992 Jun;20(5):576-81.
10
Murine epidermal gamma/delta T cells express Fc gamma receptor II encoded by the Fc gamma R alpha gene.
Eur J Immunol. 1991 Jun;21(6):1563-6. doi: 10.1002/eji.1830210635.

引用本文的文献

1
Leukocytes as paracrine regulators of metastasis and determinants of organ-specific colonization.白细胞作为旁分泌调节剂调节转移和决定器官特异性定植。
Int J Cancer. 2011 Jun 1;128(11):2536-44. doi: 10.1002/ijc.26032. Epub 2011 Mar 25.
2
Metastatic melanomas express inhibitory low affinity fc gamma receptor and escape humoral immunity.转移性黑色素瘤表达抑制性低亲和力Fcγ受体并逃避体液免疫。
Dermatol Res Pract. 2010;2010:657406. doi: 10.1155/2010/657406. Epub 2010 Jun 28.
3
The tumor microenvironment: the making of a paradigm.肿瘤微环境:一种范式的形成。
Cancer Microenviron. 2009 Sep;2 Suppl 1(Suppl 1):9-17. doi: 10.1007/s12307-009-0025-8. Epub 2009 Aug 23.
4
Fc gamma receptors and cancer.Fcγ受体与癌症
Springer Semin Immunopathol. 2006 Dec;28(4):321-8. doi: 10.1007/s00281-006-0058-8. Epub 2006 Nov 10.
5
Modulation of tumor growth by inhibitory Fc(gamma) receptor expressed by human melanoma cells.人黑色素瘤细胞表达的抑制性Fc(γ)受体对肿瘤生长的调节作用
J Clin Invest. 2002 Nov;110(10):1549-57. doi: 10.1172/JCI15454.
6
Increased levels of soluble low-affinity Fc gamma receptors (IgG-binding factors) in the sera of tumour-bearing mice.荷瘤小鼠血清中可溶性低亲和力Fcγ受体(IgG结合因子)水平升高。
Clin Exp Immunol. 1992 Feb;87(2):208-14. doi: 10.1111/j.1365-2249.1992.tb02976.x.
7
FcR may function as a progression factor of nonlymphoid tumors.Fc受体可能作为非淋巴细胞性肿瘤的进展因子发挥作用。
Immunol Res. 1992;11(3-4):283-95. doi: 10.1007/BF02919134.